Rocket Pharmaceuticals earnings were -$258.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest RCKT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$60.3M, down 9.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RCKT reported annual earnings of -$258.7M, with 5.4% growth. The next RCKT earnings date is May 5, 2025.
Rocket Pharmaceuticals Earnings Reports & History FAQ
What were Rocket Pharmaceuticals's earnings last quarter?
On RCKT's earnings call on Invalid Date, Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q4 2024 earnings per share (EPS) of -$0.62, up 0% year over year. Total RCKT earnings for the quarter were -$60.33 million. In the same quarter last year, Rocket Pharmaceuticals's earnings per share (EPS) was -$0.62.
The next RCKT earnings date is Invalid Date. Add RCKT to your watchlist to be reminded of Rocket Pharmaceuticals's next earnings date.
What was RCKT's earnings growth in the past year?
As of Rocket Pharmaceuticals's earnings date in Invalid Date, Rocket Pharmaceuticals's earnings has grown year over year. RCKT earnings in the past year totalled -$258.75 million.
Is Rocket Pharmaceuticals profitable or losing money?
As of the last Rocket Pharmaceuticals earnings report, Rocket Pharmaceuticals is currently losing money. Rocket Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$258.75 million, a 5.35% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.